Longevity Tips, The LuNa Study, AI Heart Scans, and Nrf2 Protection
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
-
Lu par :
-
De :
À propos de ce contenu audio
Send a text
Veronica Gordon, Longevity Coach, Dr. Mark Gordon, Longevity Cardiologist, and Dr. John Sledge, Medical Director of Bioshift, a non-profit Medical Research Foundation host this inaugural Longevity Lounge event from the Legendary Foods/Bioshift Offices in Santa Monica, CA.
Heart attacks shouldn’t be a plot twist. We’re walking through a smarter path to prevention that replaces population guesses with precise imaging of your own arteries. Using coronary CT angiography and AI overlays from Clearly, we can see soft versus calcified plaque, pinpoint inflammation, and measure change over time—so treatment is judged by whether your disease actually improves. That shift is at the heart of the Luna study, where we explore targeted strategies, including orally active fibrinolytic enzymes, to test whether plaque burden can truly regress rather than merely slow down.
We also get practical. The basics still matter: consistent sleep, 150 minutes of weekly movement with strength training to fight sarcopenia, hydration you can track, and a Mediterranean-leaning plate built around whole foods and adequate protein. Advanced lipid panels and personalized supplements turn vague intentions into actionable plans. For women—especially post-menopausal—the stakes are higher than most realize, with more sudden cardiovascular deaths and weaker traditional screening tools. Better imaging and individualized follow-up help close that gap fast.
Zooming in at the cellular level, we break down how Nrf2 functions as a master switch for antioxidant defenses and longevity pathways. Not all activators are equal; multi-point activation with carnosic acid from rosemary, supported by compounds like ginger and luteolin, offers a safer, broader response without the oxidative downsides of harsher approaches. Early research suggests benefits across endothelial health, mitochondrial support, cholesterol synthesis, and inflammatory control—all pieces that influence plaque stability. Put it together and you get a new standard: measure your real disease, act with precision, and remeasure to confirm results.
If you’re ready to move beyond risk scores and start managing your actual cardiovascular health, hit play, subscribe for more evidence-backed guidance, and share this with someone who needs a clearer path forward. Your heart deserves data, not guesses.
Links:
www.longevitypersonalized.com
www.bioshiftresearchfoundation.org
www.grandevitylife.com